The incorporation of TPGS in R19-loaded NPs enhanced its antiproliferative and proapoptotic activity in both hormone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cell lines. This evidence concerns the gene NR4A1 and breast carcinoma.